Search
SOLACI Congress
HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 2

RIVER-PCI: La Ranolazina no disminuye la tasa de re hospitalización o revascularización en pacientes con angina crónica y revascularización incompleta

Giora Weisz
solaci -
Learn More
Day 2

TOTAL: La aspiración de rutina en la angioplastia primaria no mejora los resultados y podría aumentar el riesgo de accidente cerebro vascular.

Sanjit S. Jolly
solaci -
Learn More
Day 2

EXPLORE: Recanalización de oclusión total crónica de vaso no culpable luego de un infarto.

Jose P.S. Henriques
solaci -
Learn More
Day 1

Estudo DRAGON: Intervenção coronária percutânea ad hoc por via radial possui efetivade clinica similar e menor taxa de sangramento maior em comparação com a...

Shigeru Saito
solaci -
Learn More
Day 1

ABSORB III: Stent bioabsorvível eluidor de everolimus é não inferior ao stent metálico eluidor de everolimus.

Original article
solaci -
Learn More
Day 1

ABSORB China: Constatação de não inferioridade em estudo prospectivo randomizado de scaffold bioabsorvível com eluição de everolimus versus stent metálico eluido em everolimus em...

Fundamentos: O stent bioabsorvível com eluição de everolimus (BVS) foi projetado para atingir resultados comparáveis ​​aos stents...
solaci -
Learn More
ESC 2015

ESC 2015

Find the most relevant articles from ESC Congress 2015. August 29 - September 02, London, UK
solaci -
Learn More
Day 3

A localização da lesão coronária associada ao risco de sangramento pode direcionar a duração da dupla terapia antiplaquetária

Fundamentos: A duração ideal da terapia antiplaquetária dupla (DAPT) após implante de stent ainda é controversa e...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy